{"status": "ok", "totalResults": 1, "articles": [{"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Donato Paolo Mancini", "title": "EU delays approval of Novavax's revised Covid jab - Financial Times", "description": "US biotech has been struggling to overcome fall in demand for coronavirus jabs", "url": "https://www.ft.com/content/2e10b2ab-7d0c-48a3-b49b-8de8dc302c6d", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252Fc9b25c15-a093-40f3-9f88-bf24f741d9bf.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2023-10-15T04:00:36Z", "content": "EU regulators have delayed a decision to approve Novavaxs variant-tailored Covid-19 vaccine, in a setback for the US-listed biotech which is battling a slump in demand for coronavirus jabs.\r\nThe Euro\u2026 [+2445 chars]"}]}